These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21087983)

  • 1. CD34, CD117, and Ki-67 expression in phyllodes tumor of the breast: an immunohistochemical study of 33 cases.
    Noronha Y; Raza A; Hutchins B; Chase D; Garberoglio C; Chu P; Weiss L; Wang J
    Int J Surg Pathol; 2011 Apr; 19(2):152-8. PubMed ID: 21087983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD34, CD117, and actin expression in phyllodes tumor of the breast.
    Chen CM; Chen CJ; Chang CL; Shyu JS; Hsieh HF; Harn HJ
    J Surg Res; 2000 Dec; 94(2):84-91. PubMed ID: 11104647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD117 and CD34 staining patterns in childhood benign mammary lesions.
    Kaçar A; Paker I; Akbiyik F; Arikök AT; Mambet E
    Turk Patoloji Derg; 2012; 28(1):31-7. PubMed ID: 22207429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases.
    Esposito NN; Mohan D; Brufsky A; Lin Y; Kapali M; Dabbs DJ
    Arch Pathol Lab Med; 2006 Oct; 130(10):1516-21. PubMed ID: 17090194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Ki-67, CD10, CD34, p53, CD117, and mast cell content in the differential diagnosis of cellular fibroadenomas and in the classification of phyllodes tumors of the breast.
    Vilela MH; de Almeida FM; de Paula GM; Ribeiro NB; Cirqueira MB; Silva AL; Moreira MA
    Int J Surg Pathol; 2014 Sep; 22(6):485-91. PubMed ID: 24492332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2005 Galloway Memorial Lecture: Breast phyllodes tumours--morphology and beyond.
    Tan PH
    Ann Acad Med Singap; 2005 Dec; 34(11):671-7. PubMed ID: 16453039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of P53, Ki-67 expression in the differential diagnosis of benign/malignant phyllodes tumors of the breast.
    Kucuk U; Bayol U; Pala EE; Cumurcu S
    Indian J Pathol Microbiol; 2013; 56(2):129-34. PubMed ID: 24056649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased c-kit (CD117) expression in malignant mammary phyllodes tumors.
    Tse GM; Putti TC; Lui PC; Lo AW; Scolyer RA; Law BK; Karim R; Lee CS
    Mod Pathol; 2004 Jul; 17(7):827-31. PubMed ID: 15044924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phyllodes tumor of the breast. A cytohistologic study of 80 cases.
    Bhattarai S; Kapila K; Verma K
    Acta Cytol; 2000; 44(5):790-6. PubMed ID: 11015981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-kit overexpression correlates with KIT gene copy numbers increases in phyllodes tumors of the breast.
    Liu J; Liu X; Feng X; Liu J; Lv S; Zhang W; Niu Y
    Breast Cancer Res Treat; 2015 Jan; 149(2):395-401. PubMed ID: 25534827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mRNA expression profiling of phyllodes tumours of the breast: identification of genes important in the development of borderline and malignant phyllodes tumours.
    Jones AM; Mitter R; Poulsom R; Gillett C; Hanby AM; Tomlinson IP; Sawyer EJ;
    J Pathol; 2008 Dec; 216(4):408-17. PubMed ID: 18937276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal and epithelial cells react differentially to c-kit in fibroepithelial tumors of the breast.
    Logullo AF; Nonogaki S; Do Socorro Maciel M; Mourão-Neto M; Soares FA
    Mol Med Rep; 2008; 1(6):857-61. PubMed ID: 21479497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An approach to malignant mammary phyllodes tumors detection.
    Ilić I; Randelović P; Ilić R; Katić V; Milentijević M; Velicković L; Krstić M
    Vojnosanit Pregl; 2009 Apr; 66(4):277-82. PubMed ID: 19441158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
    Zhang Y; Liss AL; Chung E; Pierce LJ; Kleer CG
    Breast Cancer Res Treat; 2016 Jul; 158(1):21-28. PubMed ID: 27290698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study.
    Tan PH; Jayabaskar T; Yip G; Tan Y; Hilmy M; Selvarajan S; Bay BH
    Mod Pathol; 2005 Dec; 18(12):1527-34. PubMed ID: 16258510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of Ki-67, p53, and CD10 in phyllodes tumor and their correlation with its histological grade.
    Shubham S; Ahuja A; Bhardwaj M
    J Lab Physicians; 2019; 11(4):330-334. PubMed ID: 31929699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathologic features and prognostic factors of malignant phyllodes tumors].
    Jia C; Mei F; Zheng J; You JF; Liu JY
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):729-34. PubMed ID: 24447548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD117/c-KIT Expression in Phyllodes Tumor of the Breast and Its Correlation With Morphology and Clinical Outcome.
    Jahangir S; Loya A; Mushtaq S; Akhter N; Hashmi AA
    Cureus; 2021 May; 13(5):e14914. PubMed ID: 34123614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMP3 Is Strongly Expressed in Malignant Phyllodes Tumors of the Breast: An Immunohistochemical Study.
    Bellezza G; Prosperi E; Del Sordo R; Colella R; Rulli A; Sidoni A
    Int J Surg Pathol; 2016 Feb; 24(1):37-42. PubMed ID: 26353850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors.
    Cha YJ; Koo JS
    PLoS One; 2020; 15(8):e0238466. PubMed ID: 32857809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.